anemodeanin a has been researched along with mk 2206 in 1 studies
| Studies (anemodeanin a) | Trials (anemodeanin a) | Recent Studies (post-2010) (anemodeanin a) | Studies (mk 2206) | Trials (mk 2206) | Recent Studies (post-2010) (mk 2206) |
|---|---|---|---|---|---|
| 29 | 0 | 27 | 355 | 28 | 347 |
| Protein | Taxonomy | anemodeanin a (IC50) | mk 2206 (IC50) |
|---|---|---|---|
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | 0.008 | |
| RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | 0.012 | |
| RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | 0.065 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Y; Guan, YD; Jiang, SL; Wen, M; Xiao, SS; Xu, XJ; Yu, P; Zhang, Y | 1 |
1 other study(ies) available for anemodeanin a and mk 2206
| Article | Year |
|---|---|
Suppression of eEF-2K-mediated autophagy enhances the cytotoxicity of raddeanin A against human breast cancer cells in vitro.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Breast Neoplasms; Cell Line, Tumor; Chloroquine; Down-Regulation; Elongation Factor 2 Kinase; Female; Heterocyclic Compounds, 3-Ring; Humans; Proto-Oncogene Proteins c-akt; Saponins; Signal Transduction; TOR Serine-Threonine Kinases | 2018 |